NICE rejects Lilly’s Verzenios for advanced breast cancer

15th February 2021 Uncategorised 0

CDK4 & 6 inhibitor has been available as part of a Cancer Drugs Fund (CDF) managed access agreement

More: NICE rejects Lilly’s Verzenios for advanced breast cancer
Source: News